- Home
- KZIA vs CHNR Comparison
KZIA vs CHNR Comparison
Compare KZIA & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- CHNR
- Stock Information
- Founded
- KZIA 1994
- CHNR N/A
- Country
- KZIA Australia
- CHNR China
- Employees
- KZIA N/A
- CHNR N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- KZIA Health Care
- CHNR Basic Materials
- Exchange
- KZIA Nasdaq
- CHNR Nasdaq
- Market Cap
- KZIA 5.1M
- CHNR 4.6M
- IPO Year
- KZIA 1999
- CHNR 1995
- Fundamental
- Price
- KZIA $10.45
- CHNR $3.68
- Analyst Decision
- KZIA Strong Buy
- CHNR
- Analyst Count
- KZIA 2
- CHNR 0
- Target Price
- KZIA $14.00
- CHNR N/A
- AVG Volume (30 Days)
- KZIA 745.7K
- CHNR 37.8K
- Earning Date
- KZIA 07-22-2025
- CHNR 05-15-2025
- Dividend Yield
- KZIA N/A
- CHNR N/A
- EPS Growth
- KZIA N/A
- CHNR N/A
- EPS
- KZIA N/A
- CHNR N/A
- Revenue
- KZIA $1,549,158.00
- CHNR N/A
- Revenue This Year
- KZIA N/A
- CHNR N/A
- Revenue Next Year
- KZIA N/A
- CHNR N/A
- P/E Ratio
- KZIA N/A
- CHNR N/A
- Revenue Growth
- KZIA 248983.08
- CHNR N/A
- 52 Week Low
- KZIA $2.86
- CHNR $3.35
- 52 Week High
- KZIA $79.00
- CHNR $9.04
- Technical
- Relative Strength Index (RSI)
- KZIA 72.75
- CHNR 43.59
- Support Level
- KZIA $5.86
- CHNR $3.35
- Resistance Level
- KZIA $7.20
- CHNR $3.71
- Average True Range (ATR)
- KZIA 1.17
- CHNR 0.30
- MACD
- KZIA 0.15
- CHNR -0.03
- Stochastic Oscillator
- KZIA 82.21
- CHNR 29.41
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.